| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/06/2011 | CN101519423B Betulinic acid analogue and preparation method and application thereof |
| 07/06/2011 | CN101455840B Composite capable of strengthening anti-tumor immune response |
| 07/06/2011 | CN101434616B Organotin Schiff base coordination compound, as well as preparation method and application thereof |
| 07/06/2011 | CN101421246B Structure of contact power semiconductor used on a cooling surface |
| 07/06/2011 | CN101381373B Trimethyl tin coordination compound, preparation method thereof and use |
| 07/06/2011 | CN101346382B Carbonylamino pyrrolopyrazoles, potent kinase inhibitors |
| 07/06/2011 | CN101199862B B7-1, CD40L mass particle mixture |
| 07/06/2011 | CN101181263B Treatment of respiratory diseases |
| 07/06/2011 | CN101111258B Emulsified composition for dilution and cancer vaccine composition |
| 07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
| 07/05/2011 | US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin |
| 07/05/2011 | US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/05/2011 | US7973128 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 07/05/2011 | US7973076 Stilbene derivative and a platinum coordination compound composition highly efficacious and highly safe; Diammine(1,1-cyclobutanedicarboxylato)platinum (II) |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | US7973031 Leukemia therapy ;myelodyspastic syndrome |
| 07/05/2011 | US7973024 24-sulfoximine vitamin D3 compounds |
| 07/05/2011 | US7973017 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972815 Method of producing sugar chain using human G4 polypeptide |
| 07/05/2011 | US7972609 Method of treating cancer |
| 07/05/2011 | CA2606147C Apoptosis promoters |
| 07/05/2011 | CA2583907C Heteroaryl-substituted alkyne compounds and method of use |
| 07/05/2011 | CA2555064C A pharmaceutical composition |
| 07/05/2011 | CA2486728C Novel physiologically active substances useful for suppressing vegf production |
| 07/05/2011 | CA2483228C Carboxamides |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2453845C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 07/05/2011 | CA2440160C Antitumor compositions containing taxane derivatives |
| 07/05/2011 | CA2423279C Phthalazinone derivatives |
| 07/05/2011 | CA2400185C Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 07/05/2011 | CA2398772C Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 07/05/2011 | CA2390081C Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/05/2011 | CA2380066C Antitumor antibodies, proteins, and uses thereof |
| 07/05/2011 | CA2373901C Sterile radioactive seeds |
| 07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
| 06/30/2011 | WO2011079305A1 Therapeutic compounds |
| 06/30/2011 | WO2011079304A1 Methods and compositions related to annexin 1-binding compounds |
| 06/30/2011 | WO2011079291A1 Radiopharmaceutical complexes |
| 06/30/2011 | WO2011079274A1 Aminopyrimidine kinase inhibitors |
| 06/30/2011 | WO2011079249A2 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/30/2011 | WO2011079230A2 Heterocyclic compounds as janus kinase inhibitors |
| 06/30/2011 | WO2011079193A2 Preparation of bendamustine and its salts |
| 06/30/2011 | WO2011079185A1 Anti-bv8 antibodies and uses thereof |
| 06/30/2011 | WO2011079142A2 Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
| 06/30/2011 | WO2011079133A2 Compounds and methods for kinase modulation, and indications therefor |
| 06/30/2011 | WO2011079091A1 (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses |
| 06/30/2011 | WO2011079076A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors |
| 06/30/2011 | WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | WO2011078795A1 Bridged morpholino substituted purines |
| 06/30/2011 | WO2011078782A1 A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078370A1 Novel parabanic acid derivative and drug having the same as active ingredient |
| 06/30/2011 | WO2011078312A1 Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient |
| 06/30/2011 | WO2011078311A1 Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma |
| 06/30/2011 | WO2011078250A1 Radiolabeled compound directable in vivo to target tissue and use thereof |
| 06/30/2011 | WO2011078226A1 Tricyclic compound |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078122A1 Anti-cancer agent |
| 06/30/2011 | WO2011078121A1 Anti-cancer agent |
| 06/30/2011 | WO2011078037A1 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor |
| 06/30/2011 | WO2011077171A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity |
| 06/30/2011 | WO2011077098A1 Inhibitors of akt activity |
| 06/30/2011 | WO2011077043A2 Phenol derivatives and pharmaceutical or cosmetic use thereof |
| 06/30/2011 | WO2011076922A1 Anti-flt3 antibodies and methods of using the same |
| 06/30/2011 | WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | WO2011076807A2 Lipids, lipid compositions, and methods of using them |
| 06/30/2011 | WO2011076786A1 Substituted isoquinolinones and quinazolinones |
| 06/30/2011 | WO2011076711A2 Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methylpyridine-2-carboxamide |
| 06/30/2011 | WO2011076683A1 Anti-her3 antibodies and uses thereof |
| 06/30/2011 | WO2011076547A1 Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents |
| 06/30/2011 | WO2011076327A1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds |
| 06/30/2011 | WO2011076316A1 Pyrrolopyridinyl-pyrimidin-2-ylamine derivatives |
| 06/30/2011 | WO2011076147A1 Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer |
| 06/30/2011 | WO2011076145A1 Tissue-based micro-rna methods for diagnosis of different subtypes of lung cancer |
| 06/30/2011 | WO2011076144A1 Compositions and methods for microrna expession profiling in plasma of lung cancer |
| 06/30/2011 | WO2011076143A1 Compositions and methods for microrna expression profiling of lung cancer |
| 06/30/2011 | WO2011076141A1 Diagnostic kits comprising microrna biomarkers and methods for diagnosis of hepatocellular cancer |
| 06/30/2011 | WO2011076095A1 Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells |
| 06/30/2011 | WO2011076084A1 Novel gastric cancer biomarker and uses thereof |
| 06/30/2011 | WO2011076019A1 Mixed compound medicament of natural medicine component and no donator and use thereof |
| 06/30/2011 | WO2011075957A1 Tetrahydroisoquinoline compounds, preparation methods and uses thereof |
| 06/30/2011 | WO2011075789A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | WO2011075775A1 Carrier composition |
| 06/30/2011 | WO2011056566A3 Compounds and methods for treatment of cancer |
| 06/30/2011 | WO2011054990A3 Use of 5' -methylthioadenosine for the inhibition of the epithelial-mesenchymal transition |
| 06/30/2011 | WO2011041590A3 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses |
| 06/30/2011 | WO2011041319A3 Specific binding proteins and uses thereof |
| 06/30/2011 | WO2011034887A9 A method for treating neuropathic pain |
| 06/30/2011 | WO2011031676A3 Depleting immunosuppressive monocytes within a mammal |
| 06/30/2011 | WO2011027980A9 Tumor cell-killing peptides |
| 06/30/2011 | WO2011019986A3 Processes for preparing pemetrexed |
| 06/30/2011 | WO2011017534A3 Treatment of prostate cancer |
| 06/30/2011 | WO2011017519A3 Inhibitors of methionine aminopeptidases and methods of treating disorders |
| 06/30/2011 | WO2011017350A3 Compounds as lysophosphatidic acid receptor antagonists |
| 06/30/2011 | WO2011016674A3 Novel organic germanium compounds |
| 06/30/2011 | WO2010110685A4 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |